Neuropharmacology and Central Nervous System Therapies

Neuropharmacology and central nervous system therapies focus on understanding and manipulating the biochemical, molecular, and cellular mechanisms that regulate neural function to treat neurological and psychiatric disorders. This includes modulation of neurotransmitters, ion channels, receptors, and signaling pathways to manage conditions such as Alzheimer’s disease, Parkinson’s disease, depression, epilepsy, and multiple sclerosis. Current challenges involve the complexity of the central nervous system, limited blood-brain barrier permeability, heterogeneous disease phenotypes, and variability in patient response. Emerging trends include the development of targeted small molecules, biologics, and gene-based therapies, as well as the use of nanocarriers and peptide delivery systems to improve drug penetration into the brain. Advances in molecular imaging, neurogenomics, and electrophysiological studies allow better understanding of disease mechanisms and therapeutic monitoring. Personalized medicine approaches integrate genetic, epigenetic, and biomarker data to tailor therapy to individual patients, optimizing efficacy and minimizing adverse effects. Novel strategies such as neuromodulation, stem cell-based interventions, and combination therapies are being explored to restore neuronal function and slow disease progression. Challenges also include managing long-term side effects, drug resistance, and co-morbid psychiatric or systemic conditions. Artificial intelligence and computational modeling are increasingly applied to predict therapeutic outcomes, drug interactions, and disease progression, enhancing precision therapy. Overall, neuropharmacology combines molecular insights, advanced drug delivery, and systems-level understanding to develop innovative, targeted treatments, addressing the unmet medical needs of patients with complex neurological and psychiatric disorders while advancing modern biomedicine and pharmacotherapy.

    Related Conference of Neuropharmacology and Central Nervous System Therapies

    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France
    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE

    Neuropharmacology and Central Nervous System Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in